Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Maria Grazia Fabrini
Bevacizumab and Fotemustine for Recurrent Glioblastoma: A Phase II Study of AINO (Italian Association of Neuro-Oncology)
Journal of Neuro-Oncology
Cancer Research
Oncology
Neurology
Related publications
Cost-Effectiveness Analysis of Bevacizumab, Fotemustine and Extended-Dose Temozolomide in Patients With Recurrent Glioblastoma in Spain
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Addition of Lomustine for Bevacizumab-Refractory Recurrent Glioblastoma
Acta Oncologica
Nuclear Medicine
Radiology
Hematology
Oncology
Medicine
Imaging
Bevacizumab and Chemotherapy for Recurrent Glioblastoma: A Single-Institution Experience
Neurology
Neurology
Angiotensinogen and HLA Class II Predict Bevacizumab Response in Recurrent Glioblastoma Patients
Molecular Oncology
Cancer Research
Medicine
Oncology
Genetics
Molecular Medicine
Phase II Study of Bevacizumab Plus Temozolomide During and After Radiation Therapy for Patients With Newly Diagnosed Glioblastoma Multiforme
Journal of Clinical Oncology
Cancer Research
Medicine
Oncology
Phase II Study of Bevacizumab and Vorinostat for Patients With Recurrent World Health Organization Grade 4 Malignant Glioma
Oncologist
Cancer Research
Medicine
Oncology
Neuro-Oncology Practices in Australia: A Cooperative Group for Neuro-Oncology Patterns of Care Study
Asia-Pacific Journal of Clinical Oncology
Medicine
Oncology
Phase II Study of Bevacizumab and Preoperative Chemoradiation for Esophageal Adenocarcinoma
Journal of Gastrointestinal Oncology
Oncology
Gastroenterology
Sustained Focal Antitumor Activity of Bevacizumab in Recurrent Glioblastoma
Neurology
Neurology